Evidence map›Paper›PMID 17626079›Full record

ArticleJournal of virology2007

cis effects in adeno-associated virus type 2 replication.

Peter Ward, Nathalie Clément, R Michael Linden

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Distinct YY dinucleotide periodicity in adeno-associated virus DNA.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors.Molecular therapy. Methods & clinical development · 2017
    Article
  7. Article
  8. E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Review
  9. High capsid-genome correlation facilitates creation of AAV libraries for directed evolution.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Peter WardDivision of Hematology/Oncology, Department of Geneand Cell Medicine, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA. peter.ward@mssm.edu
Nathalie Clément
R Michael Linden
Icahn School of Medicine at Mount Sinai · US

Funding

Mechanisms of the AAV2 Rep motor proteinR01GM073901 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LINDEN, RALPH MICHAEL · 2006 to 2009
$1.3M
NIGMS NIH HHS R01 GM073901NIGMS NIH HHS R01 GM 73901
6 · The paper itself

Abstract

We have utilized deletion mutants of adeno-associated virus (AAV) to investigate which elements of the AAV genome are required in cis for high yields of the wild-type virus in a plasmid transfection assay and in addition whether these elements affect primarily AAV DNA replication or encapsidation. All tested deletions from within the Rep region demonstrated a modest, approximately threefold, decrease in viral production. Deletions within the cap region resulted in markedly less virus. Previous observations suggested that in cells in which recombinant AAV (rAAV) was produced, as in our assay with the helper plasmid pDG, there is a substantial excess of empty capsids. Co-transfections of high- and low-yielding constructs demonstrated that under conditions where Cap is abundant, the constructs with cap deletions did not package efficiently. These observation suggest that the lower yields of rAAV cannot be entirely due to lack of capsids but that elements within the cap region of the wild-type genome are important for efficient encapsidation. The production of virus by the mutants we tested was, however, not consistent with the disruption of a cis-acting packaging signal. Apparently, when Cap is provided "in trans," encapsidation is inefficient. A second observation is that there were equivalent amounts of replicated but unencapsidated viral DNA in cells transfected with each of our constructs. We propose that, in accord with the previously proposed link between DNA replication and encapsidation, the total amount of AAV DNA replication can be limited by the efficiency of encapsidation.

Indexed as

CapsidCell LineDependovirusDNA-Binding ProteinsDNA ReplicationDNA, ViralGenetic Complementation TestGenome, ViralHumansPlasmidsSequence DeletionViral ProteinsVirus AssemblyVirus ReplicationDNA-Binding ProteinsDNA, Viralrep proteins, Adeno-associated virus 2Viral Proteins

Identifiers

PMID17626079
PMCPMC2045438
OpenAlexW2043292497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.